256 followers
RT @Candida_papers: Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Grea…
RT @Candida_papers: Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Grea…
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure. https://t.co/rR0kXHIZ1Z
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe #psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure. You can read the full article here: https://t.co/vltv1EEG7Q #dermatology https://t.co/QxtDB6C